: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Arsanis, Inc.(ASNS)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-10 AccNo: 0001564590-18-012719 Size: 6 MB 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2018-05-10 AccNo: 0001564590-18-012712 Size: 194 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis, Inc.(ASNS)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-23 AccNo: 0001193125-18-125788 Size: 483 KB 网页链接
$Arsanis, Inc.(ASNS)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-03-09 AccNo: 0001193125-18-076441 Size: 54 KB 网页链接
$Arsanis, Inc.(ASNS)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-09 AccNo: 0001564590-18-005038 Size: 4 MB 网页链接
$Arsanis, Inc.(ASNS)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-09 AccNo: 0001564590-18-005038 Size: 4 MB 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2018-03-09 AccNo: 0001564590-18-005034 Size: 169 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis, Inc.(ASNS)$ 8-K - Current report Filed: 2018-03-09 AccNo: 0001564590-18-005034 Size: 169 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis, Inc.(ASNS)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-02-14 AccNo: 0001193125-18-045947 Size: 224 KB 网页链接
$Arsanis, Inc.(ASNS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0000898432-18-000200 Size: 128 KB 网页链接